Ascorbic Acid Market Report 2026

The ascorbic acid market size has grown strongly in recent years. It will grow from $1.68 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to expansion of food and beverage fortification, growth of pharmaceutical manufacturing, increasing awareness of vitamin supplements, rising use in antioxidant formulations, availability of fermentation-based production methods.

The ascorbic acid market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for dietary supplements, rising focus on preventive healthcare, expansion of cosmetic anti-aging products, growing use in agricultural applications, increasing investments in nutraceutical manufacturing. Major trends in the forecast period include increasing use of ascorbic acid in functional foods, rising demand from pharmaceutical formulations, growing adoption in cosmetic applications, expansion of stabilized vitamin c derivatives, enhanced focus on immune health products.

The growing need to reduce the risk of chronic diseases is expected to drive the growth of the ascorbic acid market. Chronic diseases, such as cardiovascular diseases, cancers, chronic respiratory illnesses, and diabetes, are long-term conditions that can often be managed but not cured. Consumption of ascorbic acid and related products can help slow the progression of these diseases and improve overall health. For example, in November 2023, according to the World Health Organization (WHO), a Switzerland-based global health agency, non-communicable diseases (NCDs) remained the leading causes of death worldwide, accounting for 41 million deaths annually, or 74% of all global deaths. Therefore, the rising focus on reducing chronic disease risk is boosting demand for ascorbic acid.

Major players within the ascorbic acid market are strategically introducing cutting-edge technologies such as Fiber Interlaced Liposomal (FIL) technology to fortify their market positions. FIL technology represents an innovative approach capable of transforming liquid liposomes into a novel stabilized form of powdered liposomes. For example, in May 2023, Vidya Herbs, an India-based manufacturer specializing in plant extracts and essential oils, unveiled a new technology leveraging Fiber Interlaced Liposomal (FIL) technology to optimize vitamin C. This technological advancement ensures the seamless integration of dietary fibers and lecithin, preserving the spherical core structure of the powder. Consequently, this approach enhances the activity of liposomes, whereby the delivery vehicles for FIL facilitate a controlled release of vitamin C, enhancing absorption and minimizing breakdown within the gastrointestinal tract. The primary objective of this equilibrium optimization is to elevate bioavailability and efficacy while ensuring the sustained release of biomolecules.

In February 2024, Shiseido Americas Corporation, a U.S.-based company known for its innovative beauty products in skincare, acquired DDG Skincare Holdings LLC for an undisclosed amount. This strategic move aims to enhance Shiseido's portfolio by incorporating a dermatologist-developed skincare line celebrated for its innovative, science-based products. DDG Skincare Holdings, also based in the U.S., specializes in offering ascorbic acid in its skincare formulations.

Major companies operating in the ascorbic acid market are Koninklijke DSM N.V., Northeast Pharmaceutical Group Co. Ltd., CSPC Pharmaceutical Group, Bactolac Pharmaceutical Inc., BASF SE, LabChem Inc., Muby Chemicals Pvt. Ltd., Foodchem International Corporation, Bayer AG, North China Pharmaceutical Group, Sigma-Aldrich Corporation, The Bountiful Company, Homart Pharmaceuticals Pty Ltd., Archer-Daniels-Midland Company, Amway Corporation, Tirlán Co-operative Society Limited, Changsha Natureway Co. Ltd., DSM Nutritional Products AG, Glanbia PLC, Gujchem Biotech, Hangzhou Go Top Peptide Biotech Co. Ltd., Hebei Welcome Pharmaceutical Co. Ltd., Huachang Pharmaceuticals, LGM Pharma LLC, Nutrilo GmbH, Shaanxi Iknow Biotechnology Co. Ltd., Shandong Luwei Pharmaceutical, Sichuan Tongsheng Amino Acid Co. Ltd.

Asia-Pacific was the largest region in the ascorbic acid market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ascorbic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ascorbic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ascorbic acid market consists of sales of dehydroascorbate, calcium threonate, xylonate, lyxonate, and L-ascorbic acid, industrial grade, cosmetic grade, and liquid and powder form. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.